Kennis & ervaring
Specialisme / subspecialisme:
- Acute lymfatische leukemie
- Chronische myeloide leukemie
- Immunotherapie/geneesmiddelenstudies
- Fase I/II studies
Werkervaring
2001-2006 kinderarts in opleiding, ErasmusMC-Sophia Kinderziekenhuis Rotterdam
2006-2008 fellow kinderoncologie, ErasmusMC-Sophia Kinderziekenhuis Rotterdam
2008-2018 kinderoncoloog ErasmusMC-Sophia Kinderziekenhuis Rotterdam
2016-heden kinderoncoloog, Prinses Máxima Centrum voor Kinderoncologie, Utrecht
Promotie
2002: promotie Erasmus Universiteit/Sophia Kinderziekenhuis Rotterdam: ‘Bone Mineral Densitiy in Health and Disease’.
Opleiding
2010-2012: klinisch farmacoloog, ErasmusMC Rotterdam
2006-2008: kinderoncoloog, ErasmusMC-Sophia Kinderziekenhuis Rotterdam
2001-2006: kinderarts, ErasmusMC-Sophia Kinderziekenhuis Rotterdam
1997-2001: promotieonderzoek, Erasmus Universiteit Rotterdam
1989-1996: geneeskunde (cum laude) Universiteit van Nijmegen
BIG-registratie
29045880101
Publicaties
I van der Sluis, A Möricke, G Escherich, A von Stackelberg, W Holter, T Klingebiel, C Flotho, S Legien, W Tissing, M Bierings, C Guimbal-Schmolck, U Pichlmeier, HJ Kühnel, R Pieters. Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia. Haematologica 2013; 98:1697-1701.
WH Tong, R Pieters, GJL Kaspers, MWM te Loo, MB Bierings, C van den Bos, WJW Kollen, WCJ Hop, J Boos, MV Relling, HJ Kuehnel, WJ Tissing, IM van der Sluis, A prospective study on therapeutic drug monitoring of PEGasparaginase and Erwinia asparaginases and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood 2014;123:2026-33.
K Schmiegelow, A Attarbaschi, S Barzilai, G Escherich, T Leth Frandsen, C Halsey, R Hough, M Kato, Der-Cherng Liang, T Stamm Mikkelsen, A Möricke, R Niinimäki, C Piette, M Catarina Putti, E Raetz, S Jeha, L Silverman, R Skinner, R Tuckuviene, I van der Sluis, E Zapotocka - on behalf of the Ponte di Legno toxicity working group. Consensus definitions of severe toxicities during childhood acute lymphoblastic leukaemia therapy. Lancet Oncology 2016;17:231-9.
IM van der Sluis, LM. Vrooman, R Pieters, A Baruchel, G Escherich, N Goulden, V Mondelaers, J Sanchez de Toledo, C Rizzari, L.B. Silverman, JA Whitlock. Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica 2016;101:279-85
K Schmiegelow, IM van der Sluis. Book: Childhood Acute Lymphoblastic Leukaemia. Chapter 8: Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of antileukemic drugs. Publisher: Springer International Publishing. Edition 1, 2017; page 99-138. ISBN 978-3-319-39708-5
Voor meer publicaties: PubMed.